Recombinant Human NMNAT1 Protein，His

Nicotinamide mononucleotide adenylyl transferase 1 (NMNAT1) is a crucial enzyme involved in the biosynthesis of nicotinamide adenine dinucleotide (NAD+), a vital cofactor essential for various cellular processes, including energy metabolism, DNA repair, and cell signaling. NMNAT1 specifically catalyzes the conversion of nicotinamide mononucleotide (NMN) to NAD+, playing a significant role in maintaining cellular NAD+ levels. Recent studies have revealed that NAD+ depletion is associated with various age-related diseases, neurodegenerative disorders, and metabolic dysfunctions, making NMNAT1 a potential target for therapeutic interventions. The recombinant expression of NMNAT1 protein allows for detailed biochemical investigations into its enzymatic activity, regulatory mechanisms, and interaction with other cellular proteins. Understanding the structure-function relationship of NMNAT1 through recombinant studies can aid in the development of NAD+-boosting strategies, including dietary supplements and pharmacological agents, geared towards promoting healthspan and mitigating age-associated decline. Furthermore, the characterization of NMNAT1 could provide insights into its role in diseases such as Alzheimer’s and diabetes, where NAD+ homeostasis is disrupted. Thus, the research on NMNAT1 recombinant protein is pivotal in elucidating the intricate pathways of NAD+ metabolism and exploring novel therapeutic avenues to enhance cellular health and longevity.